Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04799431
Title Neoantigen-Targeted Vaccine Combined With Anti-PD-1 Antibody for Patients With Stage IV MMR-p Colon and Pancreatic Ductal Cancer
Recruitment Not yet recruiting
Phase Phase I
Variant Requirements No
Sponsors Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

colon cancer

pancreatic cancer


Neoantigen peptide vaccine + Poly ICLC + Retifanlimab

Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.